Search clinical trials for: Natural Killer Cells

Total 11980 results

The First People's Hospital of Changzhou

Active, not recruiting

CIK in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms
NKMAX Co., Ltd.

Recruiting

A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment (SNK_ASTER)

Non-small Cell Lung Cancer

Korea, Republic of
Zhongnan Hospital

Recruiting

Clinical Study of MAK Immune Cells in the Treatment of PHC

Primary Hepatocellular Carcinoma

China
The First People's Hospital of Changzhou

Not yet recruiting

CIK in Treating Patients With Esophageal Cancer

Esophageal Squamous Cell Carcinoma
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

Melanoma (Skin)

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IIIA Fallopian Tube Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA Primary Peritoneal Cancer AJCC v8 | Stage IIIA1 Fallopian Tube Cancer AJCC v8 | Stage... and other conditions

United States
Yanjuan Zhu

Unknown

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer (CIKCC)

Colonic Neoplasms

China
Monica Thakar

Completed

Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors (STIR)

Osteosarcoma | Ewing Sarcoma | Neuroblastoma | Rhabdomyosarcoma | CNS Tumors

United States
SMT bio Co., Ltd.

Completed

Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer

Biliary Tract Cancer

Korea, Republic of
Ivy Life Sciences, Co., Ltd
Tri-Service General Hospital

Unknown

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Liver Cancer | HepatoCellular Carcinoma

Taiwan
Sheng Hu
Wuhan Binhui Biotechnology Co., Ltd.

Recruiting

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Malignant Pleural Effusion | Malignant Peritoneal Effusion

China
Casa Sollievo della Sofferenza IRCCS
Ministry of Health, Italy

Recruiting

Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS) (STEMALS)

Amyotrophic Lateral Sclerosis

Italy
Alliancells-PuRui Biocience Co., Ltd.
Zhongyuan Union Stem Cell Bio-engineering Corporation

Unknown

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Renal Cell Carcinoma | Hepatocellular Carcinoma | Lung Cancer

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Ovarian Carcinoma
Xiaoyi Huang

Unknown

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Renal Cell Carcinoma | Nasopharyngeal Carcinoma | Colorectal Cancer | Lung Cancer

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Cholangiocarcinoma

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Cervical Cancer
Guangxi Medical University

Unknown

Study of DC-CIK to Treat Colorectal Cancer

Colorectal Cancer

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat NPC

Nasopharyngeal Carcinoma

China
S.Biomedics Co., Ltd.
Yonsei University; Linical Co., Ltd.

Recruiting

Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI (SB-SCI-001)

Spinal Cord Injury, Acute | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C4 Level With Complete Lesion

Korea, Republic of
University Hospital, Bordeaux

Completed

Influence of Natural Images on Patients' Anxiety in the Waiting Rooms of Imaging Ward (VERTIM)

All Conditions for Which a CT or MRI Exam Can be Required

France
Ivy Life Sciences, Co., Ltd

Completed

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

Lung Cancer | Liver Cancer | NSCLC Stage IV | Hepatocellular Carcinoma by BCLC Stage | NSCLC Stage IIIB
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Rituximab and NK Immunotherapy for B Lymphoma

B-cell Lymphoma Recurrent

China
Sun Yat-sen University

Completed

CIK Treatment for HCC Patient Underwent Radical Resection

Carcinoma, Hepatocellular

China
Masonic Cancer Center, University of Minnesota
Miltenyi Biomedicine GmbH

Withdrawn

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission

Acute Myelogenous Leukemia

United States
Antonio Pérez Martínez

Recruiting

Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas (SANKOMA)

Malignant Sarcoma

Spain
The First People's Hospital of Changzhou

Active, not recruiting

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

Colorectal Neoplasms
Capital Health, Canada
Sunnybrook Health Sciences Centre; Erasmus Medical Center; IWK Health Centre; Afexa... and other collaborators

Completed

Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors

Respiratory Tract Infection

Canada, Netherlands
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)

Terminated

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
FullHope Biomedical Co., Ltd.
Taipei Veterans General Hospital, Taiwan

Unknown

Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Neoplasm Metastasis | Colorectal Neoplasms | Hepatocellular Carcinoma
StemCells, Inc.

Withdrawn

Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis

Neuronal Ceroid Lipofuscinosis

United States
Universidad Europea de Madrid

Completed

Hypoalgesic Effect of Neural Mobilization

Cervicobrachial Neuralgia

Venezuela
New Approaches to Neuroblastoma Therapy Consortium
Nationwide Children's Hospital; United Therapeutics

Active, not recruiting

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

Neuroblastoma

United States
Institute of Biophysics and Cell Engineering of...
Belarusian State Medical University

Not yet recruiting

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Bladder Cancer | Renal Cancer

Belarus
Cornell University

Completed

Nature as a Buffer Among People With Chronic Pain

Chronic Pain

United States
Cairo University

Completed

Mobilization With Movement vs. Neural Mobilization on Nerve Root Function in Patients With Cervical Radiculopathy

Cervical Radiculopathy | Disc Herniation | Cervical Radiculopathy at C5 Nerve Root | Cervical Radiculopathy at C6 Nerve Root | Cervical Radiculopathy at C7 Nerve Root

Egypt
Affiliated Hospital to Academy of Military Medical...

Unknown

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Non-Small-Cell Lung Cancer With Bone Metastases

China
Azienda Ospedaliera Santa Maria, Terni, Italy
Azienda Ospedaliero Universitaria Maggiore della Carita; Università di Padova...

Completed

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) (hNSCALS)

Amyotrophic Lateral Sclerosis

Italy
Navy General Hospital, Beijing
Daping Hospital and the Research Institute of Surgery of the Third Military... and other collaborators

Unknown

Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy

Hypoxic-Ischemic Encephalopathy

China
University of Arkansas
Bristol-Myers Squibb; Altor BioScience

Withdrawn

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Multiple Myeloma

United States
Baylor College of Medicine
Center for Cell and Gene Therapy, Baylor College of Medicine; Alex's Lemonade...

Withdrawn

3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA (GINAKIT)

Neuroblastoma

United States
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer

Small Cell Lung Cancer

China
The First People's Hospital of Changzhou

Completed

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Colorectal Cancer

China
Masonic Cancer Center, University of Minnesota

Completed

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
IRCCS San Raffaele
Fondazione Italiana Sclerosi Multipla

Completed

Neural Stem Cell Transplantation in Multiple Sclerosis Patients (STEMS)

Progressive Multiple Sclerosis

Italy
Guangxi Medical University

Unknown

A Study of DC-CIK to Treat Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
Gary Steinberg, MD, PhD
California Institute for Regenerative Medicine (CIRM)

Recruiting

A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)

Ischemic Stroke

United States
Xuanwu Hospital, Beijing

Recruiting

Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease

Parkinson's Disease

China
The First People's Hospital of Changzhou

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
Altor BioScience
M.D. Anderson Cancer Center

Withdrawn

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States

Search clinical trials for: Natural Killer Cells

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations